APA (7th ed.) Citation

Foley, P., Tsai, T., Rodins, K., Hamadah, I. R., Ammoury, A., Dayem, H. A., . . . Huang, Y. (2022). Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study. Dermatology & Therapy, 12(2), 511. https://doi.org/10.1007/s13555-021-00675-w

Chicago Style (17th ed.) Citation

Foley, Peter, et al. "Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study." Dermatology & Therapy 12, no. 2 (2022): 511. https://doi.org/10.1007/s13555-021-00675-w.

MLA (9th ed.) Citation

Foley, Peter, et al. "Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study." Dermatology & Therapy, vol. 12, no. 2, 2022, p. 511, https://doi.org/10.1007/s13555-021-00675-w.